LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Mitoxantrone | 0.37 | uM | LJP5 | 72 | hr | 765 | 628 | 3124 | 0.2010 | -0.0581 |
Hs 578T | Pelitinib | 10.0 | uM | LJP5 | 72 | hr | 765 | 628 | 3124 | 0.2011 | -0.0579 |
MCF 10A | Mitoxantrone | 3.33 | uM | LJP6 | 72 | hr | 1694 | 630 | 11155 | 0.0565 | -0.1125 |
BT-20 | Torin2 | 3.33 | uM | LJP5 | 72 | hr | 1334 | 631 | 3970 | 0.1590 | -0.2668 |
Hs 578T | HG-5-113-01 | 10.0 | uM | LJP5 | 72 | hr | 765 | 631 | 3124 | 0.2022 | -0.0565 |
Hs 578T | AZD7762 | 0.12 | uM | LJP6 | 72 | hr | 765 | 632 | 3124 | 0.2025 | -0.0561 |
MDA-MB-231 | LDN-193189 | 10.0 | uM | LJP5 | 72 | hr | 1311 | 641 | 5013 | 0.1279 | -0.1811 |
MDA-MB-231 | Fedratinib | 10.0 | uM | LJP5 | 72 | hr | 1311 | 642 | 5013 | 0.1281 | -0.1809 |
Hs 578T | PD0325901 | 10.0 | uM | LJP5 | 72 | hr | 765 | 643 | 3124 | 0.2060 | -0.0514 |
BT-20 | Mitoxantrone | 1.11 | uM | LJP6 | 72 | hr | 1334 | 645 | 3970 | 0.1626 | -0.2614 |
Hs 578T | R406 | 10.0 | uM | LJP6 | 72 | hr | 765 | 646 | 3124 | 0.2070 | -0.0502 |
Hs 578T | NVP-AEW541 | 10.0 | uM | LJP5 | 72 | hr | 765 | 647 | 3124 | 0.2071 | -0.0500 |
BT-20 | Withaferin A | 3.33 | uM | LJP5 | 72 | hr | 1334 | 647 | 3970 | 0.1629 | -0.2609 |
BT-20 | GW843682X | 10.0 | uM | LJP6 | 72 | hr | 1334 | 648 | 3970 | 0.1633 | -0.2604 |
Hs 578T | Luminespib | 3.33 | uM | LJP5 | 72 | hr | 765 | 649 | 3124 | 0.2077 | -0.0492 |
MDA-MB-231 | AZD 5438 | 10.0 | uM | LJP6 | 72 | hr | 1311 | 652 | 5013 | 0.1301 | -0.1781 |
Hs 578T | WYE-125132 | 10.0 | uM | LJP6 | 72 | hr | 765 | 658 | 3124 | 0.2108 | -0.0451 |
MCF7 | CGP60474 | 0.12 | uM | LJP6 | 72 | hr | 1389 | 659 | 5667 | 0.1164 | -0.1705 |
Hs 578T | Mitoxantrone | 0.37 | uM | LJP6 | 72 | hr | 765 | 661 | 3124 | 0.2117 | -0.0440 |
Hs 578T | Crizotinib | 10.0 | uM | LJP5 | 72 | hr | 765 | 662 | 3124 | 0.2119 | -0.0437 |
Hs 578T | Nilotinib | 10.0 | uM | LJP5 | 72 | hr | 765 | 662 | 3124 | 0.2121 | -0.0434 |
Hs 578T | Luminespib | 0.37 | uM | LJP5 | 72 | hr | 765 | 664 | 3124 | 0.2127 | -0.0425 |
MCF7 | PF431396 | 10.0 | uM | LJP5 | 72 | hr | 1389 | 665 | 5667 | 0.1173 | -0.1692 |
BT-20 | Torin2 | 10.0 | uM | LJP5 | 72 | hr | 1334 | 667 | 3970 | 0.1681 | -0.2530 |
Hs 578T | Mitoxantrone | 0.12 | uM | LJP6 | 72 | hr | 765 | 669 | 3124 | 0.2141 | -0.0407 |